Telix dips as FDA knocks back new drug for imaging rare brain cancer – despite prior approval
Telix (ASX:TLX) has copped a sharp jab on Monday as the FDA…
Telix Pharmaceuticals Limited (ASX:TLX)
About Telix Pharmaceuticals Limited
Key Information
TLX In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 28/04/2025 | Price Sensitive PS Telix Provides Regulatory Update on TLX101-CDx | 140.77KB | 18K |
| 24/04/2025 | Pending Release of Shares from Voluntary Escrow | 139.61KB | 847 |
| 22/04/2025 | Price Sensitive PS Telix Reports US$186M Q1 Revenue, Up 62% YOY | 214.9KB | 55K |
| 22/04/2025 | Pending Release of Shares from Voluntary Escrow | 137.47KB | 410 |
| 17/04/2025 | Telix Notice of AGM, Proxy Form and Online Guide | 3.33MB | 456 |
| 16/04/2025 | IPAX-Linz Promising Efficacy for TLX101 Glioma Tx Candidate | 152.97KB | 8.4K |
| 14/04/2025 | Change of Registry Address Notification | 67.5KB | 491 |
| 07/04/2025 | Telix Responds to Recent U.S. Government Actions | 140.09KB | 12K |